APA (7th ed.) Citation

Javor, E., Belančić, A., Javor, P., Hauser, G., Kruljac, I., Skelin, M., . . . Lucijanić, M. (2025). Aspirin Versus LMWH for Thromboprophylaxis Following Hip or Knee Arthroplasty—Clinical Implications and Budget Impact. Pharmacology Research & Perspectives, 13(4), 1. https://doi.org/10.1002/prp2.70147

Chicago Style (17th ed.) Citation

Javor, Eugen, Andrej Belančić, Patrik Javor, Goran Hauser, Ivan Kruljac, Marko Skelin, Andrea Faour, and Marko Lucijanić. "Aspirin Versus LMWH for Thromboprophylaxis Following Hip or Knee Arthroplasty—Clinical Implications and Budget Impact." Pharmacology Research & Perspectives 13, no. 4 (2025): 1. https://doi.org/10.1002/prp2.70147.

MLA (9th ed.) Citation

Javor, Eugen, et al. "Aspirin Versus LMWH for Thromboprophylaxis Following Hip or Knee Arthroplasty—Clinical Implications and Budget Impact." Pharmacology Research & Perspectives, vol. 13, no. 4, 2025, p. 1, https://doi.org/10.1002/prp2.70147.